Companies

Krystal Biotech, Inc. (KRYS) SEC filings

CIK 0001711279 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Revenue (USD)389.1 M0
Net income (USD)204.8 M-140.0 M
Diluted EPS (USD/shares)6.84-5.49

Latest filings

FiledFormDescriptionPeriod
2026-10-158-K8-K items 7.01,9.012026-10-15
2026-09-164FORM 42026-09-14
2026-09-164FORM 42026-09-14
2026-09-164FORM 42026-09-14
2026-09-164FORM 42026-09-14
2026-09-164FORM 42026-09-14
2026-09-164FORM 42026-09-14
2026-09-044FORM 42026-09-04
2026-09-044FORM 42026-09-04
2026-09-04144144
2026-09-04144144
2026-08-144FORM 42026-08-14
2026-08-14144144
2026-08-038-K8-K items 2.02,9.012026-08-03
2026-08-0310-Q10-Q2026-06-30
2026-07-218-K8-K items 8.01,9.012026-07-21
2026-06-264FORM 42026-06-25
2026-06-25144144
2026-06-054FORM 42026-06-04
2026-06-054FORM 42026-06-04
2026-06-04144144
2026-06-04144144
2026-05-274FORM 42026-05-26
2026-05-26144144
2026-05-208-K8-K items 5.072026-05-15

Forms on file (last 1,000): 4 160, 8-K 110, 144 56, SC 13G/A 35, 10-Q 27, 3 18, SC 13G 16, 424B5 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=KRYS (0.002 USD), /gw/filings/filings?ticker=KRYS&form=8-K, /gw/filings/facts?ticker=KRYS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange